Dr. Riolin C. Andrade, MD

Dr. Andrade practices at HealthAlliance Hospital in Kingston, New York, part of Westchester Medical Center Health Network.

Dr. Andrade's NPI, 1780686071, was assigned on June 1, 2005. Dr. Andrade graduated from Bangalore Medical College in 1972. Dr. Andrade holds New York license 165872-1.

Dr. Andrade's primary practice is HealthAlliance Hospital, at 105 Mary's Avenue, Kingston, NY 12401 in Ulster County. The practice phone is (845) 338-2500.

Dr. Andrade's primary practice is HealthAlliance Hospital in Kingston, New York, part of Westchester Medical Center Health Network. Dr. Andrade is also affiliated with Westchester Medical Center. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Andrade to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andrade practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Andrade's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Andrade's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Andrade treats.

CMS data shows 572 Medicare services from Dr. Andrade across 6 procedure codes in 2024, for 224 Medicare patients. Medicare paid $52,803 for them. Every service was in an office.

CMS counts 224 Medicare patients who saw Dr. Andrade in 2024. The largest group is 75 to 84, with 103 patients. 75% of them have cancer, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Andrade's median patient age at 73, with 62% women.

In 2024, Dr. Andrade wrote 92 Medicare Part D claims for 33 patients. 76% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $171 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Andrade for performance year 2024, reported as part of a group. Dr. Andrade accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Andrade as offering telehealth.

CMS Open Payments shows 346 general payments to Dr. Andrade from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Puma Biotechnology, Inc. paid the most, $1,076.

Dmand AI lists 1 award for Dr. Andrade, most recently CMS Stage 1 EHR in 2012.

Dr. Andrade graduated from Bangalore Medical College in 1972. Dr. Andrade is a member of ASCO.

Dr. Andrade is in network with 15 carriers, including Aetna, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.